OPIA Technologies Overview
- Founded
- 2009
- Status
- Private
- Employees
- 2
- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $3.33M
- Investors
- 2
OPIA Technologies General Information
Description
Developer of medical devices in particular ocular surface sampling devices designed for diagnostic purposes. The company's services offer a technology platform for in vivo biopsies of the conjunctiva for further analysis to help diagnose the most common ocular surface disorders such as dry eye, allergies, or blepharitis, enabling clients in the healthcare sector to provide innovative and reliable devices to improve the diagnosis and care of patients with ocular diseases.
Contact Information
Website
www.opiatech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
- 17, Rue Moreau
- 75012 Paris
- France
+33 01 00 00 00 00
OPIA Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 03-Mar-2014 | $3.33M | 00.000 | 000.00 | Completed | Generating Revenue |
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
OPIA Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 |
OPIA Technologies Patents
OPIA Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160354239-A1 | Ocular iontophoresis device | Granted | 27-Jan-2014 | 0000000000 | 0 |
| CA-2937929-A1 | Ocular iontophoresis device | Abandoned | 27-Jan-2014 | 0000000000 | |
| ES-2672327-T3 | Eye iontophoresis device | Active | 27-Jan-2014 | 0000000000 | |
| US-10478333-B2 | Ocular iontophoresis device | Active | 27-Jan-2014 | 0000000000 | 00 |
| EP-2898922-B1 | Ocular iontophoresis device | Active | 27-Jan-2014 | A61F9/0017 |
OPIA Technologies Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Pierre Roy | Co-Founder, Chief Executive Officer & President |
OPIA Technologies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialOPIA Technologies Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Agoranov | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| Incubateur Insitut de La Vision | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |